Literature DB >> 32069206

Mixed Serous and Clear Cell Adenocarcinoma of the Ovary Presenting with Symptomatic Hypercalcemia: A Case Report and Clinical Considerations.

Julia L Boland1, Darius Shahbazi1, Stephen E Wang1, Shahin Z Shahbazi1.   

Abstract

INTRODUCTION: Hypercalcemia is a common phenomenon in patients with cancer but is more common among certain cancer types. Hypercalcemia in ovarian cancer is the common presenting sign in small cell carcinoma of the ovary, hypercalcemic type; however, there are no known documented cases of hypercalcemia as the presenting sign for mixed serous and clear cell adenocarcinoma. This case report describes symptomatic hypercalcemia as the presenting sign of mixed serous and clear cell carcinoma of the ovary. CASE
PRESENTATION: A 60-year-old woman with a medical history of hypertension and hyperlipidemia presented to the outpatient clinic with weakness, nausea, emesis, constipation, and an unintended 9-kg (20-lb) weight loss. Her calcium level was elevated at 15.7 mg/dL (reference range = 8.5-10.3 mg/dL). She was treated for hypercalcemia and subsequently admitted to the hospital 4 times because of recurrence of symptoms. On outpatient workup, she was noted to have an abnormal positron emission tomography scan showing intense activity in the uterus consistent with malignancy. An exploratory laparotomy with total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and lymph node staging was performed, and pathologic findings demonstrated high-grade ovarian carcinoma with serous and clear cell features. DISCUSSION: Hypercalcemia is a rare but possible primary presenting symptom of ovarian cancer. In these patients, serum calcium measurements could possibly serve as a tumor marker for disease.

Entities:  

Mesh:

Year:  2020        PMID: 32069206      PMCID: PMC7021138          DOI: 10.7812/TPP/19.125

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  10 in total

1.  A case of ovarian cancer associated with hypercalcemia.

Authors:  Morio Sawada; Takashi Uehara
Journal:  Jpn J Clin Oncol       Date:  2008-10       Impact factor: 3.019

Review 2.  The diagnosis and management of hypercalcaemia.

Authors:  Salvatore Minisola; Jessica Pepe; Sara Piemonte; Cristiana Cipriani
Journal:  BMJ       Date:  2015-06-02

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 4.  Hypercalcaemia - presentation and management .

Authors:  Jeremy J O Turner
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

5.  Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases.

Authors:  R H Young; E Oliva; R E Scully
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

Review 6.  Screening for ovarian cancer.

Authors:  K J Carlson; S J Skates; D E Singer
Journal:  Ann Intern Med       Date:  1994-07-15       Impact factor: 25.391

7.  Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma.

Authors:  S Lewin; D Dezube; Ak Guddati; K Mittal; F Muggia; Paula Klein
Journal:  Ecancermedicalscience       Date:  2012-10-02

8.  Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms.

Authors:  Xuegong Ma; Yingmei Wang; Xuhong Zhang; Mengting Dong; Wen Yang; Fengxia Xue
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

9.  Identifying symptoms of ovarian cancer: a qualitative and quantitative study.

Authors:  C R Bankhead; C Collins; H Stokes-Lampard; P Rose; S Wilson; A Clements; D Mant; S T Kehoe; J Austoker
Journal:  BJOG       Date:  2008-07       Impact factor: 6.531

10.  Prevalence of hypercalcemia among cancer patients in the United States.

Authors:  Victor M Gastanaga; Lee S Schwartzberg; Rajul K Jain; Melissa Pirolli; David Quach; Jane M Quigley; George Mu; W Scott Stryker; Alexander Liede
Journal:  Cancer Med       Date:  2016-06-05       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.